BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12694851)

  • 1. Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon.
    Sunyach MP; Pommier P; Martel Lafay I; Guyotat J; Ginestet G; Jouanneau E; Jouvet A; Sindou M; Bret P; Carrie C; Frappaz D
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):296-303. PubMed ID: 12694851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
    Soffietti R; Rudà R; Bradac GB; Schiffer D
    Neurosurgery; 1998 Nov; 43(5):1066-73. PubMed ID: 9802850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of anaplastic oligodendrogliomas and mixed gliomas.
    Kyritsis AP; Yung WK; Bruner J; Gleason MJ; Levin VA
    Neurosurgery; 1993 Mar; 32(3):365-70; discussion 371. PubMed ID: 8455760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Levin VA
    Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy.
    Lebrun C; Fontaine D; Bourg V; Ramaioli A; Chanalet S; Vandenbos F; Lonjon M; Fauchon F; Paquis P; Frenay M
    Eur J Neurol; 2007 Apr; 14(4):391-8. PubMed ID: 17388986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
    Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
    Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ
    N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
    ; Cairncross G; Berkey B; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Laperierre N; Mehta M; Curran W
    J Clin Oncol; 2006 Jun; 24(18):2707-14. PubMed ID: 16782910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation and chemotherapy improve outcome in oligodendroglioma.
    Allison RR; Schulsinger A; Vongtama V; Barry T; Shin KH
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):399-403. PubMed ID: 9069313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of conformal radiation therapy for pediatric low-grade glioma.
    Merchant TE; Kun LE; Wu S; Xiong X; Sanford RA; Boop FA
    J Clin Oncol; 2009 Aug; 27(22):3598-604. PubMed ID: 19581536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of low-grade oligodendroglial tumors without radiotherapy.
    Higuchi Y; Iwadate Y; Yamaura A
    Neurology; 2004 Dec; 63(12):2384-6. PubMed ID: 15623706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.
    Wang M; Cairncross G; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Laperriere N; Mehta M; Curran W; ; ; ; ;
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):662-9. PubMed ID: 19783377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
    Cairncross G; Swinnen L; Bayer R; Rosenfeld S; Salzman D; Paleologos N; Kaminer L; Forsyth P; Stewart D; Peterson K; Hu W; Macdonald D; Ramsay D; Smith A;
    Neuro Oncol; 2000 Apr; 2(2):114-9. PubMed ID: 11303620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.
    Streffer J; Schabet M; Bamberg M; Grote EH; Meyermann R; Voigt K; Dichgans J; Weller M
    J Neurol; 2000 Apr; 247(4):297-302. PubMed ID: 10836623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
    Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
    Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.
    Narayana A; Yamada J; Berry S; Shah P; Hunt M; Gutin PH; Leibel SA
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):892-7. PubMed ID: 16458777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
    Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T
    Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.